The Role of Botulinum Toxin A Neuromodulator in the Management of Synkinesis in Facial Palsy

Asalet Yener,Vikas Acharya,Peter Andrews,Catherine Meller,Eamon Shamil
DOI: https://doi.org/10.1055/a-2370-2426
2024-08-30
Facial Plastic Surgery
Abstract:Facial palsy describes the denervation of the facial nerve leading to difficulty in facial animation and expression. Facial synkinesis is the result of complex pathological nerve regeneration following damage to the facial nerve axons. Synkinesis in facial palsy can be managed using facial neuromuscular rehabilitation, botulinum toxin neuromodulators, and surgical treatment options. Botulinum toxin A can be used as an adjunct to other treatment options to manage synkinesis. This article will explore the role of botulinum toxin A in the management of synkinesis in facial palsy including the clinical assessment, injection location (muscles targeted), dosages, treatment interval, and long-term results. It will also include surgical management options. Accepted Manuscript online: 22 July 2024 Article published online: 27 August 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
surgery
What problem does this paper attempt to address?